Vir enlists Covid-19 antibody rival for cancer, infectious disease discovery work
Vir — Bob Nelsen and George Scangos’ infectious disease startup — is going into immuno-oncology.
Enlisting Harbour BioMed as a partner, Vir will tap the trans-Pacific biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.